# GentiBio: Biotechnology, Cambridge, United States

> GentiBio: GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to...

Source: https://millionrounds.com/startup/gentibio (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# GentiBio

GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to address Type 1 diabetes and other i

Funding reported Last round: Series A

Biotechnology Cambridge, United States

Company summary

- **Founded:** 2020 6 years old
- **Team:** 43 11 to 50 people
- **Funding reported:** $177M in dollars
- **Last round:** Series A Aug 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for GentiBio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About GentiBio

GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to address Type 1 diabetes and other i

mmune-related diseases. The company aims to improve autoimmune and acute inflammatory conditions by suppressing inflammation in a targeted manner while promoting tissue healing and restoring immune balance. Headquartered in Cambridge, Massachusetts, GentiBio utilizes a proprietary modular engineering platform to create stable and scalable EngTregs. This platform combines patient-derived and donor-derived technologies to enhance immune tolerance. The company's therapeutic pipeline includes a specific candidate named GNTI-122, with a primary focus on curing Type 1 diabetes and addressing conditions such as Inflammatory Bowel Disease, Systemic Lupus Erythematosus, and Multiple Sclerosis. GentiBio has raised $177 million from notable investors, including Bristol-Myers Squibb and Novartis, to support its mission and future collaborations.

## What company datasets say GentiBio raised

Funding, as reported

Reported in all **$177M** in dollars

Rounds **2**

Last round **Series A**

Last round size **$157M**

Last round date **Aug 2021**

Investors listed **7**

## Founders and team

From GentiBio's own website: 1 on the team.

- **Nathan Zammit** Principal Scientist

## On 2 portfolio pages

Investors who name them

- [T1D Fund](https://millionrounds.com/fund/t1d-fund)
- [OrbiMed](https://millionrounds.com/fund/orbimed)

Each firm lists GentiBio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

b2b

Built with from their website

Google Cloud Google Cloud Hosting Microsoft Exchange Microsoft 365 Apps & Services Microsoft Exchange Online Microsoft 365 Google Cloud DNS Outlook Microsoft Email Providers

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714
- **Region:** Massachusetts
- **Revenue:** $2.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/gentibio)

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put GentiBio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)